Strategies to guide the successful implementation of deprescribing in community practice: Lessons learned from the front line

• Published in: Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
• Main Authors: Turner, Justin P., Newport, Kelda, McEvoy, Aisling M., Smith, Tara, Tannenbaum, Cara, Kelly, Deborah V.
• Other Authors: Department of Health and Community Services, Government of Newfoundland and Labrador, fonds de recherche du québec - santé, mitacs
• Format: Article in Journal/Newspaper
• Language: English
• Published: SAGE Publications 2024
• Subjects: Newfoundland
• Online Access: http://dx.doi.org/10.1177/17151635241240737; https://journals.sagepub.com/doi/pdf/10.1177/17151635241240737; https://journals.sagepub.com/doi/full-xml/10.1177/17151635241240737

Background: Sustainable implementation of new professional services into clinical practice can be difficult. In 2019, a population-wide initiative called SaferMedsNL was implemented across the province of Newfoundland and Labrador (NL), to promote appropriate medication use. Two evidence-based interventions were adapted to the context of NL to promote deprescribing of proton pump inhibitors and sedatives. The objective of this study was to identify and prioritize which actions supported the implementation of deprescribing in community practice for pharmacists, physicians and nurse practitioners across the province. Methods: Community pharmacists, physicians and nurse practitioners were invited to participate in virtual focus groups. Nominal Group Technique was used to elicit responses to the question: “What actions support the implementation of deprescribing into the daily workflow of your practice?” Participants prioritized actions within each group while thematic analysis permitted comparison across groups. Results: Five focus groups were held in fall 2020 involving pharmacists ( n = 11), physicians ( n = 7) and nurse practitioners ( n = 4). Participants worked in rural ( n = 10) and urban ( n = 12) settings. The different groups agreed on what the top 5 actions were, with the top 5 receiving 68% of the scores: (1) providing patient education, (2) allocating time and resources, (3) building interprofessional collaboration and communication, (4) fostering patient relationships and (5) aligning with public awareness strategies. Conclusion: Pharmacists, physicians and nurse practitioners identified similar actions that supported implementing evidence-based deprescribing into routine clinical practice. Sharing these strategies may help others embed deprescribing into daily practice and assist the uptake of medication appropriateness initiatives by front-line providers. Can Pharm J (Ott) 2024;157:xx-xx.